Correlation between anti-interferon-beta binding and neutralising antibodies in multiple sclerosis patients on interferon-beta therapy

被引：0
|
作者：
Jensen, P. E. H. [1 ]
Sellebjerg, F. [1 ]
Sondergaard, H. B. [1 ]
Sorensen, P. S. [1 ]
机构：
[1] Rigshosp, DK-2100 Copenhagen, Denmark
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P306
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [21] Preserved in vivo response to interferon-alpha in multiple sclerosis patients with neutralising antibodies against interferon-beta (REPAIR study)
    Magyari, Melinda
    Sondergaard, Helle Bach
    Sellebjerg, Finn
    Sorensen, Per Soelberg
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (02) : 141 - 146
  • [22] Neutralising antibodies to interferon beta during the treatment of multiple sclerosis
    Giovannoni, G
    Munschauer, FE
    Deisenhammer, F
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (05): : 465 - 469
  • [23] Predictive markers to interferon-beta therapy in multiple sclerosis patients
    Charbit, H.
    Geyshis, B.
    Karussis, D.
    Petrou, P.
    Smith, Y.
    Vaknin-Dembinsky, A.
    Lavon, I.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S232 - S233
  • [24] Interferon-beta specific T cells are associated with the development of neutralizing antibodies in interferon-beta treated multiple sclerosis patients
    Kalluri, Sudhakar Reddy
    Grummel, Verena
    Hracsko, Zsuzsanna
    Pongratz, Viola
    Pernpeintner, Verena
    Gasperi, Christiane
    Buck, Dorothea
    Hemmer, Bernhard
    JOURNAL OF AUTOIMMUNITY, 2018, 88 : 83 - 90
  • [25] Multiple sclerosis patients lacking antibodies in cerebrospinal fluid are less likely to develop neutralising antibodies against interferon-beta
    Lundqvist, M.
    Greiner, E.
    Imrell, K.
    Hillert, J.
    Fogdell-Hahn, A.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S19 - S20
  • [26] Measurement of antibodies binding to interferon beta in Iranian multiple sclerosis patients treated with interferon beta
    Hooshmand, F.
    Jangouk, P.
    Vaezeafshar, R.
    Lotfi, J.
    Nikbin, B.
    Amirzargar, A. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 266 - 267
  • [27] Neutralising antibodies to interferon-beta in multiple sclerosis: technical report and validation of a cytopathic effect assay
    Massart, C.
    Oger, J.
    Grossberg, S. E.
    Gibassier, J.
    Le Page, E.
    Edan, G.
    MULTIPLE SCLEROSIS, 2006, 12 : S201 - S201
  • [28] Measuring Neutralising Antibodies to interferon-beta: A neglected practice?
    McKee, Jon
    Spence, Robert
    Hughes, Stella
    Droogan, Aidan
    Gray, Orla
    Campbell, Jamie
    McDonnell, Gavin
    NEUROLOGY, 2021, 96 (15)
  • [29] Evaluation of anti-interferon beta neutralising antibodies in subjects with relapsing multiple sclerosis
    Farrell, Rachel A.
    Leary, Siobhan
    Rudge, Peter
    Thompson, Alan
    Miller, David
    Giovannoni, Gavin
    NEUROLOGY, 2007, 68 (12) : A117 - A117
  • [30] Correlation of neutralising antibody status with side effects of interferon beta therapy in patients with multiple sclerosis
    Cossoy, M. B.
    Rush, C.
    Campbell, T. L.
    Kremenchutzky, M.
    Bhan, V.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 : S61 - S61
12345